Product Usage: This product is intended for research purposes only.
All product information available on this website is for educational purposes only. Any form of bodily introduction into humans or animals is strictly prohibited by law. This product should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Bemethyl (100mg/capsule) 60 Capsules
During our packaging transition, you may receive products with either our previous or updated label. Rest assured, the formulation, purity and quality remain exactly same as standards.
Bemethyl is a synthetic bromine-substituted benzimidazole derivative classified as an actoprotector, a class of compounds investigated for their effects on cellular stress adaptation and metabolic resilience. Unlike classical CNS stimulants, Bemethyl is studied for its reported influence on intracellular pathways involved in protein synthesis, energy metabolism, and adaptation to physiological stressors. Experimental research has examined its effects on metabolic regulation, cellular stress-response mechanisms, and adaptation-related signalling pathways in preclinical models. Research applications include actoprotector pharmacology, stress-adaptation pathway investigation, metabolic regulation studies, and comparative analysis within the benzimidazole compound class.
- High Purity – 99% Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
3D Molecular Structure
Drag to rotate · scroll to zoom| Chemical Formula | C9H11BrN2S |
|---|---|
| Synonyms | Antihot, Bemiton, Betamyl, Metaprot, 63513-71-3, TG4SAK8A5M |
| Molar Mass | 259.17 g/mol |
| CAS Number | 109628-14-0 |
| PubChem CID | 9816609 |
| Total Compound Content | 6000mg (100mg per capsule) |
| Shelf Life | 24 months |
Every batch is independently lab tested for identity, purity and potency. View our lab testing program →
How does Bemethyl's proposed mechanism differ from classical CNS stimulants in stress-adaptation research?
Unlike classical stimulants that primarily act through dopaminergic or adrenergic pathways, Bemethyl is investigated for its reported effects on metabolic adaptation and cellular stress-response mechanisms. Research has focused on endpoints related to energy metabolism, protein synthesis, and recovery from physiological stress rather than direct neurotransmitter receptor activation. Comparative studies often combine receptor-binding data with metabolic biomarkers to distinguish actoprotector activity from stimulant pharmacology.
What experimental endpoints are used to characterize Bemethyl's stress-adaptation profile?
Research commonly utilizes exercise, thermal stress, and hypoxia models, with endpoints including endurance capacity, stress tolerance, glycogen metabolism, glucose kinetics, lactate dynamics, and markers of protein or RNA synthesis. These measurements allow investigators to examine relationships between functional performance outcomes and underlying metabolic adaptations.
What structural class does Bemethyl belong to?
Bemethyl is a brominated benzimidazole derivative. Its benzimidazole scaffold places it within a broader class of compounds studied across multiple areas of pharmacological research, while its specific substitution pattern and actoprotector classification make it a useful tool for investigating stress-adaptation mechanisms, metabolic regulation, and structure-activity relationships within the benzimidazole family.
-
-
SALE
-
-
SALE
-
